CIBERDEM

DIATRAIN Mobility Fellowships

DIATRAIN Fellowships

DIATRAIN Fellowships
   
About CIBERDEM

Incoming Mobility Program

Outgoing Mobility Program

Status of the calls

FAQs

Help Desk
   diatrain(at)ciberdem(dot)org
   +3493 212 0647
   69 Bonanova Av., 6th floor
   08017 Barcelona (Spain)

Find us on Facebook and Twitter

Starting in 2011, the DIAbetes Trans-national Research Advancement for INvestigators (DIATRAIN) is the new institutional mobility framework promoted by CIBERDEM. Enclosed under the FP7-People Co-funding of Regional, National and International Program (FP7-People-2010-COFUND) of the European Commission, DIATRAIN aims to provide worldwide outstanding experienced researchers with unique career development opportunities.

The DIATRAIN mobility framework is structured into two mobility schemes, the Outgoing Mobility Programme (COMP) and the Incoming Mobility Programme (CIMP). Both schemes will provide postdoctoral fellowships, aimed at promoting the mobility of experienced researchers from and to CIBERDEM consortium research institutions.

International researchers may approach any of the available research groups from CIBERDEM through the CIMP mobility scheme, while the COMP mobility scheme may be used by CIBERDEM staff members to develop their research careers abroad.

DIATRAIN will open annual selection processes for both CIMP and COMP schemes, in order to select top-class researchers to benefit from the postdoctoral fellowships.

News


COMP PROGRAM

3rd COMP Call: The third call of our COMP program is now open. Three fellowships will be granted to carry out stays at foreign institutions. Deadline: 2 January 2014

3rd Extra COMP Call: The third extraordinary call of our COMP program is closed and three fellowships have been awarded. Fellows will carry out their research projects at the University of Pennsylvania (USA), the Columbia University Medical Center (USA) and the Oxford Centre for Diabetes, Endocrinology and Metabolism of the University of Oxford (UK).

2nd Extra COMP Call: The second extraordinary call of our COMP program closed without any candidates.

2nd COMP Call: The second call of our COMP program is closed and one fellowship has been awarded. The fellow will carry out the research project at the University of Cambridge (UK).

1st Extra COMP Call: The first extraordinary call of our COMP program is closed and one fellowship has been awarded. The fellow will carry out the research project at the Mount Sinai Medical School in New York (USA).

1st COMP Call: The first call of our COMP program is closed and two fellowships have been awarded. Fellows will carry out their research projects at the Centre de Pharmacologie & Innovation dans le Diabète and at the Institut de Génétique Moléculaire de Montpellier, both in Montpellier (France).

More information about the individual calls can be found on the Status of the Call section. Click here to be redirected

CIMP PROGRAM

2nd CIMP Call: The second and last call of our CIMP program is closed and two fellowships have been awarded. Fellows will carry out their research projects in the groups of Dr. Ramon Gomis and Dr. Héctor Escobar.

1st Extra CIMP Call: The first extraordinary call of our CIMP program is closed and one fellowship has been awarded. The Fellow will carry out the research project in the group of Dr. Luis Castaño

1st CIMP Call: The first call of our CIMP program is closed and one fellowship has been awarded. The Fellow will carry out the research project in the group of Dr. Jorge Ferrer

More information about the individual calls can be found on the Status of the Call section. Click here to be redirected

Dates
January 2nd, 2014
COMP Application deadline OPEN

January 16th, 2013
CIMP Application deadline CLOSED



About CIBERDEM
The Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorder is a public research consortium made up of 31 research groups based in different hospitals, universities and research centres throughout Spain. It offers a wide range of technological facilities, thus providing an important platform for translating basic research into innovation. (read more)

 

 

Logo